Home

Selezionare Circonferenza Strumento jto clinical and research reports impact factor aspettare Dovrebbero Spettatore

JTO Clinical and Research Reports
JTO Clinical and Research Reports

JTO Clinical and Research Reports - Journal - Elsevier
JTO Clinical and Research Reports - Journal - Elsevier

Journal of Thoracic Oncology | Elsevier Pharma Solutions
Journal of Thoracic Oncology | Elsevier Pharma Solutions

Journals | IASLC
Journals | IASLC

IASLC | International Association for the Study of Lung Cancer
IASLC | International Association for the Study of Lung Cancer

JTO Clinical and Research Reports
JTO Clinical and Research Reports

Journals | IASLC
Journals | IASLC

Home Page: JTO Clinical and Research Reports
Home Page: JTO Clinical and Research Reports

Home Page: JTO Clinical and Research Reports
Home Page: JTO Clinical and Research Reports

Home Page: JTO Clinical and Research Reports
Home Page: JTO Clinical and Research Reports

PDF) A Systematic Review and Meta-analysis of Clinical Characteristics and  Outcomes in Lung Cancer Patients with COVID-19
PDF) A Systematic Review and Meta-analysis of Clinical Characteristics and Outcomes in Lung Cancer Patients with COVID-19

Journals | IASLC
Journals | IASLC

Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration

Subscribe to Journal of Thoracic Oncology - 1556-0864
Subscribe to Journal of Thoracic Oncology - 1556-0864

Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration

Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus  Disease 2019 Pandemic in the People's Republic of China - ScienceDirect
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China - ScienceDirect

JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses  the @IASLC #WCLC19 General Assembly, describing the incredible growth of  the JTO (including a new impact factor of 12.460) and
JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses the @IASLC #WCLC19 General Assembly, describing the incredible growth of the JTO (including a new impact factor of 12.460) and

JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses  the @IASLC #WCLC19 General Assembly, describing the incredible growth of  the JTO (including a new impact factor of 12.460) and
JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses the @IASLC #WCLC19 General Assembly, describing the incredible growth of the JTO (including a new impact factor of 12.460) and

Home Page: JTO Clinical and Research Reports
Home Page: JTO Clinical and Research Reports

JTO Clinical and Research Reports
JTO Clinical and Research Reports

IASLC | International Association for the Study of Lung Cancer
IASLC | International Association for the Study of Lung Cancer